Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent’s Disease
Nephron Physiology · 20.06.2009 · 112 (4) · p53-p62
DOI: 10.1159/000225944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephron Physiology, online erschienen am 20.06.2009. Verfasst von Fiona Wu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Medicine, Academic Endocrine Unit, University of Oxford, and Churchill Hospital, Oxford Centre for Diabetes, Endocrin…. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
Background/Aims: Dent’s disease is caused by mutations in the chloride/proton antiporter, CLC-5, or oculo-cerebro-renal-syndrome-of-Lowe (OCRL1) genes.
Methods
Eighteen probands with Dent’s disease were investigated for mutations in CLC-5 and two of its interacting proteins, CLC-4 and cofilin. Wild-type and mutant CLC-5s were assessed in kidney cells. Urinary calcium excretion following an oral calcium challenge was studied in one family.
Results
Seven different CLC-5 mutations consisting of two nonsense mutations (Arg347Stop and Arg718Stop), two missense mutations (Ser244Leu and Arg516Trp), one intron 3 donor splice site mutation, one deletion-insertion (nt930delTCinsA) and an in-frame deletion (523delVal) were identified in 8 patients. In the remaining 10 patients, DNA sequence abnormalities were not detected in the coding regions of CLC-4 or cofilin, and were independently excluded for OCRL1. Patients with CLC-5 mutations were phenotypically similar to those without. The donor splice site CLC-5 mutation resulted in exon 3 skipping. Electrophysiology demonstrated that the 523delVal CLC-5 mutation abolished CLC-5-mediated chloride conductance. Sixty percent of women with the CLC-5 deletion-insertion had nephrolithiasis, although calcium excretion before and after oral calcium challenge was similar to that in unaffected females.
Conclusions
Three novel CLC-5 mutations were identified, and mutations in OCRL1, CLC-4 and cofilin excluded in causing Dent’s disease in this patient cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Clinical Medicine, Academic Endocrine Unit, University of Oxford, and Churchill Hospital, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.
Förderung
- Medical Research Council
- Wellcome Trust
Zitieren
APA
Wu, F., Reed, A. A., Williams, S. E., Loh, N. Y., Lippiat, J. D., Christie, P. T., Large, O., Bettinelli, A., Dillon, M. J., Goldraich, N. P., Hoppe, B., Lhotta, K., Loirat, C., Malik, R., Morel, D., Kotanko, P., Roussel, B., Rubinger, D., Schrander-Stumpel, C., …, & Thakker, R. V. (2009). Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent’s Disease. Nephron Physiology, 112(4), p53-p62. https://doi.org/10.1159/000225944
Vancouver
Wu F, Reed AA, Williams SE, Loh NY, Lippiat JD, Christie PT, et al. Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent’s Disease. Nephron Physiology. 2009;112(4):p53-p62. doi:10.1159/000225944
BibTeX
@article{Wu2009,
author = {Wu, Fiona and Reed, Anita A C and Williams, Sian E and Loh, Nellie Y and Lippiat, Jonathan D and Christie, Paul T and Large, Oliver and Bettinelli, Alberto and Dillon, Michael J and Goldraich, Noemia P and Hoppe, Bernd and Lhotta, Karl and Loirat, Chantal and Malik, Rayaz and Morel, Delphine and Kotanko, Peter and Roussel, Bernard and Rubinger, Dvora and Schrander-Stumpel, Connie and Serdaroglu, Erkin and Nesbit, M Andrew and Ashcroft, Frances and Thakker, Rajesh V},
title = {Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent’s Disease},
journal = {Nephron Physiology},
year = {2009},
volume = {112},
number = {4},
pages = {p53--p62},
doi = {10.1159/000225944}
}
EUVIMED